Sildenafil and the Pharmaceutical Sector : A Risky Venture ?

The legacy of Viagra, and its creator copyright, presents a complex case study for investors. Initially a blockbuster drug, generating billions in income, its patent expiration created a wave of lower-priced alternatives , significantly diminishing its market share . While specific pharmaceutical companies may attempt to capitalize on similar condi

read more